20425 ⎘
Medicinal preparations containing organic active ingredients; Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two nitrogen atoms as the only ring heteroatoms, e.g. piperazine; Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim having oxo groups directly attached to the heterocyclic ring, e.g. cytosine Barbituric acids; Derivatives thereof, e.g. sodium pentobarbital
COMPOSITIONS, FORMULATIONS, AND METHODS FOR HAIR TREATMENT
#2METHODS FOR THE TREATMENT OF HYPERTENSION VIA TRANSCRANIAL-FOCUSED-ULTRASOUND
#3NOVEL FORMULATION
#4ANALYTE SENSOR
#53-(5-SUBSTITUTED-4-OXOQUINAZOLIN-3(4H)-YL)-3-DEUTERO-PIPERIDINE-2,6-DIONE DERIVATIVES AND COMPOSITIONS COMPRISING AND METHODS OF USING THE SAME
#6CANNABINOIDS IN THE TREATMENT OF EPILEPSY
#7ENZYME IMMOBILIZED ADHESIVE LAYER FOR ANALYTE SENSORS
#8DAPRODUSTAT FOR REDUCING FATIGUE IN A SUBJECT WITH ANEMIA ASSOCIATED WITH CHRONIC KIDNEY DISEASE
#9APPLICATION OF PHD2 INHIBITOR IN PREPARATION OF DRUGS FOR PREVENTION AND TREATMENT OF PLATELET THROMBUS
#10PHARMACEUTICAL COMPOSITION FOR TOPICAL WOUND TREATMENT
#11METHODS OF P21 SUPPRESSION FOR BONE REGENERATION AND HEALING
#12HIF-1 ACTIVATORS AND USES THEREOF
#13METHODS FOR INHIBITING PARASITIC GLUCOKINASE AND/OR HEXOKINASE
#14SMALL MOLECULE INHIBITORS OF INTERFERON GAMMA SIGNALING
#15METHODS AND COMPOSITIONS FOR TREATMENT OF EPILEPTIC DISORDERS
#16METHODS AND COMPOSITIONS FOR TREATMENT OF EPILEPTIC DISORDERS
#17SOLID STATE FORMS OF DAPRODUSTAT AND PROCESS FOR THEIR PREPARATION
#18STABILIZATION OF PHENOBARBITAL SODIUM FOR INJECTION
#19AGENT FOR USE IN THE TREATMENT OF GLIOMA
#20Pharmaceutical Composition And Method For Treating Seizure Disorders
#21NOVEL MANUFACTURING METHOD OF DAPRODUSTAT AND PRECURSORS THEREOF
#22USE OF CANNABINOIDS IN THE TREATMENT OF EPILEPSY
#23ANALYTE SENSOR
#24STABILIZATION OF PHENOBARBITAL SODIUM FOR INJECTION
#25Methods and compositions for treatment of epileptic disorders
#26COMPOUNDS AND METHODS TO TARGET GLUCOSE-STIMULATED PHOSPHOHISTIDINE SIGNALING AND ESOPHAGEAL CANCER GROWTH
#27BACTERIAL DNA GYRASE INHIBITORS AND METHODS OF USE THEREOF
#28Use of cannabinoids in the treatment of epilepsy
#29Methods and compositions for treatment of epileptic disorders
#30Methods and compositions for treatment of epileptic disorders
#31USE OF [(1R)-1-(2-CHLOROPHENYL)-2-(TETRAZOL-2-YL)ETHYL] CARBAMATE IN COMBINATION THERAPY
#32IMMEDIATE RELEASE ABUSE-DETERRENT GRANULATED DOSAGE FORMS
#33USE OF CANNABIDIOL IN THE TREATMENT OF SEIZURES ASSOCIATED WITH RARE EPILEPSY SYNDROMES RELATED TO GENETIC ABNORMALITIES
#34BIOMARKERS AND METHODS FOR DETECTION OF SEIZURES AND EPILEPSY
#35COMPOUND AND METHOD FOR TREATING DISEASES AND DISORDERS
#36TREATMENT FOR PSORIASIS AND SKIN INFLAMMATORY DISEASES
#37Prolyl Hydroxylase Inhibitors
#38FORMULATION COMPRISING DAPRODUSTAT
#39Lyophilized compositions of phenobarbital sodium salt
#40DIFFUSION RESISTANCE LAYER FOR ANALYTE SENSORS
#41DIFFUSION RESISTANCE LAYER FOR ANALYTE SENSORS
#42COMPOSITIONS, FORMULATIONS, AND METHODS FOR HAIR TREATMENT
#43METHODS OF TREATING TUMORS
#44Combination therapy
#45Stabilization of phenobarbital sodium for injection
#46USE OF THE PHYTOCANNABINOID CANNABIDIOL (CBD) IN COMBINATION WITH A STANDARD ANTI-EPILEPTIC DRUG (SAED) IN THE TREATMENT OF EPILEPSY
#47Use of cannabinoids in the treatment of epilepsy
#48Methods and compositions for treatment of epileptic disorders
#49RETINA REGENERATION THROUGH EPIGENETICS MANIPULATION
#50Lyophilized Compositions of Phenobarbital Sodium Salt
#51Methods and compositions for treatment of epileptic disorders
#52SULFUR (VI) FLUORIDE COMPOUNDS AND METHODS FOR THE PREPARATION THEREOF
#53METHODS TO PREVENT, INHIBIT OR TREAT INTERVERTEBRAL DISC DEGENERATION
#54Pharmaceutical composition for topical wound treatment
#55MEMBRANE LAYERS FOR ANALYTE SENSORS
#56Agent for use in the treatment of glioma
#57CANNABINOIDS IN THE TREATMENT OF EPILEPSY
#58THERAPEUTIC COMBINATIONS, LIQUID PHARMACEUTICAL COMPOSITIONS, KITS FOR THEIR PREPARATION, AND METHODS OF THEIR USE
#59Immediate release abuse-deterrent granulated dosage forms
#60Inhibitor for V-Atpase Activity, Antibacterial Agent, Medicine, Antibacterial Method and Screening Method
#613-(5-substituted-4-oxoquinazolin-3(4H)-yl)-3-deuteropiperidine-2,6-dione derivatives and compositions comprising and methods of using the same
#62INDOLE MOLECULES AND USE THEREOF IN THE INHIBITION OF DNA POLYMERASES
#63Immediate release abuse-deterrent granulated dosage forms
#64COMPOSITIONS AND METHODS FOR TREATING DISEASES ASSOCIATED WITH UNCONTROLLED INFLAMMATORY RESPONSES
#65SULFUR (VI) FLUORIDE COMPOUNDS AND METHODS FOR THE PREPARATION THEREOF
#66Use of cannabinoids in the treatment of epilepsy
#67ENZYME IMMOBILIZED ADHESIVE LAYER FOR ANALYTE SENSORS
#68COMBINATION THERAPIES FOR TREATMENT OF INFLAMMATORY DISEASES
#69Prolyl hydroxylase inhibitors
#70Pharmaceutical composition for topical wound treatment
#71SEIZURE CONTROL COMPOSITIONS AND METHODS OF USING SAME
#72Compositions and methods for treating diseases associated with uncontrolled inflammatory responses
#73Pharmaceutical composition and method for treating seizure disorders
#74Systems and methods for monitoring neural activity
#75COMPOSITIONS AND METHODS FOR TREATING REFRACTORY SEIZURES
#76METHODS AND COMPOSITIONS FOR TREATMENT OF EPILEPTIC DISORDERS
#77SELECTIVE CALCIUM CHANNEL ANTAGONISTS
#78METHODS FOR TREATING LIVER DISEASES
#79NEW USE AND METHODS OF MODULATING IMMUNE RESPONSES
#80Use of the phytocannabinoid cannabidivarin (CBDV) in the treatment of epilepsy
#81Use of cannabinoids in the treatment of epilepsy
#82Therapy for post-traumatic osteoarthritis
#83Immediate release abuse-deterrent granulated dosage forms
#84Lyophilized compositions of phenobarbital sodium salt
#85THERAPEUTIC APPROACHES FOR TREATING EPILEPSY AND RELATED DISORDERS THROUGH REDUCTION OF EPILEPTOGENESIS
#86Use of [(1R)-1-(2-chlorophenyl)-2-(tetrazol-2-yl)ethyl] carbamate in combination therapy
#87Methods and compositions for treatment of epileptic disorders
#88Sulfur (VI) fluoride compounds and methods for the preparation thereof
#89Pharmaceutical compositions
#90GABA A receptor agonists for treatment of disorders influenced by dysfunction BETA cells
#91COMPOSITION FOR TREATING SEIZURE DISORDERS
#92USE OF CANNABINOIDS IN THE TREATMENT OF EPILEPSY
#93SEIZURE CONTROL COMPOSITIONS AND METHODS OF USING SAME
#94Compositions and methods for inhibiting PTPN22
#95Biomarkers and methods for detection of seizures and epilepsy
#96Arylfluorosulfate compounds and methods
#97PHARMACEUTICAL COMPOSITIONS
#98PHARMACEUTICAL COMPOSITIONS
#99ABUSE-PROOFED DOSAGE FORM
#100Methods and compositions for treatment of epileptic disorders
#101USE OF CANNABINOIDS IN THE TREATMENT OF EPILEPSY
#102Prolyl Hydroxylase Inhibitors
#103Immediate release abuse-deterrent granulated dosage forms
#104Method for treating damage induced by sleep deprivation
#105PHARMACEUTICAL COMPOSITIONS
#106PREVENTATIVE THERAPY FOR POST-TRAUMATIC OSTEOARTHRITIS
#107Use Of [(1R)-1-(2-Chlorophenyl)-2-(Tetrazol-2-YL)Ethyl] Carbamate In Combination Therapy
#1083-(5-substituted-4-oxoquinazolin-3(4H)-yl)-3-deutero-piperidine-2,6-dione derivatives and compositions comprising and methods of using the same
#109Methods and compositions for treatment of epileptic disorders
#110Compositions and methods for reducing overdose
#111Non-extractable oral solid dosage forms
#112Methods and compositions for treatment of epileptic disorders
#113TREATING OCULAR NEOVASCULARIZATION
#114METHODS AND COMPOSITIONS USING IMMUNOMODULATORY COMPOUNDS FOR TREATMENT AND MANAGEMENT OF CANCERS AND OTHER DISEASES
#115SELECTIVE CALCIUM CHANNEL ANTAGONISTS
#116ARYLFLUOROSULFATE COMPOUNDS AND METHODS
#117Immediate release abuse-deterrent granulated dosage forms
#118METHODS AND COMPOSITIONS FOR TREATMENT OF EPILEPTIC DISORDERS
#119Outpatient modified rapid detoxification for addiction to alcohol and drugs
#120ABUSE-PROOFED DOSAGE FORM
#121Sulfur(VI) fluoride compounds and methods for the preparation thereof
#122ANTIVIRAL COMPOUNDS AND METHODS OF USE THEREOF
#123PHARMACEUTICAL COMPOSITIONS
#124METHODS AND COMPOSITIONS FOR TREATMENT OF EPILEPTIC DISORDERS
#125Use of cannabinoids in the treatment of epilepsy
#126PHARMACEUTICAL COMPOSITIONS
#127Prolyl hydroxylase inhibitors
#128Inhibitors of glucose kinases, along with methods of their formation and use
#129ABUSE-PROOFED DOSAGE FORM
#130Agents for use in the treatment of glioma
#131N-substituted hydroxamic acids with carbon-based leaving groups as efficient HNO donors and uses thereof
#132Immediate release abuse-deterrent granulated dosage forms
#133Preventative therapy for post-traumatic osteoarthritis
#134Composition and method for treating seizure disorders
#135Tyrosine kinase inhibition as a treatment for epilepsy
#136METHODS AND COMPOSITIONS FOR TREATMENT OF EPILEPTIC DISORDERS
#137Method for determining sensitivity to fluorouracil in a subject having colorectal cancer
#138Treatment of epileptic disorders in feline animals
#139Pharmaceutical compositions
#140Method for treating liver diseases of various origins
#141PHARMACEUTICAL COMPOSITIONS
#142Compositions and methods comprising medium chain triglycerides for treatment of epilepsy
#143PHARMACEUTICAL COMPOSITIONS
#144PHARMACEUTICAL COMPOSITIONS
#145Pharmaceutical compositions
#146Methods for rescuing phenobarbital-resistance of seizures by ANA-12 or ANA-12 in combination with CLP290
#147LIPOSOME-BASED MUCUS-PENETRATING PARTICLES FOR MUCOSAL DELIVERY
#148Compositions and methods for reducing overdose
#149Use of cannabinoids in the treatment of epilepsy
#150Sulfur(VI) fluoride compounds and methods for the preparation thereof
#151BIOINTERFACE LAYER FOR ANALYTE SENSORS
#152Enzyme immobilized adhesive layer for analyte sensors
#153Membrane layers for analyte sensors
#154BIOINTERFACE LAYER FOR ANALYTE SENSORS
#1553-(5-substituted-4-oxoquinazolin-3(4H)-yl)-3-deutero-piperidine-2,6-dione derivatives and compositions comprising and methods of using the same
#156Compositions and methods for reducing overdose
#157Stable formulation of phenobarbital sodium injection
#158Immediate release abuse-deterrent granulated dosage forms
#159Methods for treating multiple myeloma with 3-(4-amino-1-oxo-1,3-dihydroisoindol-2-yl)-piperidine-2,6-dione after stem cell transplantation
#160Compositions and methods for reducing overdose
#161Compositions and methods for reducing overdose
#162Treating ocular neovascularization
#163Medicinal drug with activity against gram positive bacteria, mycobacteria and fungi
#164Stabilization of alcohol intoxication-induced cardiovascular instability
#165Outpatient modified rapid detoxification for addiction to alcohol and drugs
#166Abuse-proofed dosage form
#167Pharmaceutical compositions
#168Process for the production of an abuse-proofed dosage form
#169TOPICAL COMPOSITIONS COMPRISING MODULATORS OF TRPM8
#170Immediate release abuse-deterrent granulated dosage forms
#171Selective calcium channel antagonists
#172Prolyl hydroxylase inhibitors
#173Methods for treating newly diagnosed multiple myeloma with 3-(4-amino-1-OXO-1,3-dihydroisoindol-2-yl)-piperidine-2,6-dione in combination with second active agents
#174Method for treating liver diseases of various origins
#175IMMEDIATE RELEASE ABUSE-DETERRENT GRANULATED DOSAGE FORMS
#176COMPOSITIONS, METHODS OF USE, AND METHODS OF TREATMENT
#177Method of treating glioma
#178HNF4-alpha ANTAGONIST AND USE THEREOF
#179Compositions and methods comprising medium chain triglycerides for treatment of epilepsy
#180Antiviral compounds and methods of use thereof
#181Pharmaceutical compositions
#182Allosteric inhibitors of thymidylate synthase
#183N-hydroxylamino-barbituric acid derivatives
#184Pharmaceutical compositions
#185Compositions and methods for reducing overdose
#186Medicinal drug with activity against gram positive bacteria, mycobacteria and fungi
#187Use of cannabinoids in the treatment of epilepsy
#188Indole compounds for use in treating inflammation and cancer
#189Use of the phytocannabinoid cannabidivarin (CBDV) in the treatment of epilepsy
#190Pharmaceutical compositions
#191Pharmaceutical compositions
#192Pharmaceutical compositions
#193Treatment of epileptic disorders in feline animals
#194Methods using 3-(4-amino-1-oxo-1,3-dihydro-isoindol-2-yl)-piperidine-2,6-dione for treatment of certain leukemias
#195C-Rel inhibitors and uses thereof
#196Shikimate pathway inhibitors and the use thereof
#197Immediate release abuse-deterrent granulated dosage forms
#198Immediate release abuse-deterrent granulated dosage forms
#199Immediate Release Abuse-Deterrent Granulated Dosage Forms
#200Immediate Release Abuse-Deterrent Granulated Dosage Forms
#201Immediate Release Abuse-Deterrent Granulated Dosage Forms
#202Methods for treating non-hodgkin's lymphoma with 3-(4-amino-1-oxo-1,3-dihydro-isoindol-2-yl)-piperidine-2,6-dione in combination with a second active agent
#203Use of dihydroimidazolones for the treatment of dogs
#204Methods for treating newly diagnosed multiple myeloma 3-(4-amino-1-oxo-1,3-dihydro-isoindol-2-yl)-piperidine-2,6-dione in combination with dexamethasone
#205Treatments involving eslicarbazepine acetate or eslicarbazepine
#206Methods for treating multiple myeloma with 3-(4-amino-1-oxo-1,3-dihydro-isoindol-2-yl)-piperidine-2,6-dione after stem cell transplantation
#207STAT3 Inhibitors
#208Methods for treating non-hodgkin's lymphoma with 3-(4-amino-1-oxo-1,3-dihydroisoindol-2-yl)-piperidine-2,6-dione in combination with a second active agent
#209Methods for treating amyloidosis with 3-(4-amino-1-oxo-1,3-dihydroisoindol-2-yl)-piperidine-2,6-dione
#210Methods for treating multiple myeloma using 4-(amino)-2-(2,6-dioxo(3-piperidyl))-isoindoline-1,3-dione in combination with antibodies
#211Methods using 3-(4-amino-1-oxo-1,3-dihydro-isoindol-2-yl)-piperidine-2,6-dione for treatment of certain leukemias
#212Marker for determination of sensitivity to anticancer agent
#2136,7-dihydro-[1,3,4]thiadiazolo-[3,2-a][1,3]diazepin derivatives and pharmaceutical compositions containing the same as hypnotic or anesthetic agent and method for their preparation
#214Pharmaceutical compositions
#215ACTIVATING PHOSPHORYLATION SITE ON GLUTAMINASE C
#216METHODS FOR INHIBITION OF CELL PROLIFERATION, SYNERGISTIC TRANSCRIPTION MODULES AND USES THEREOF
#217Anti-human urothelial carcinoma of supercritical carbon dioxide extract of , and the preparation process and uses
#218Treatment of prolonged status epilepticus
#219Antiviral compounds and methods of use thereof
#220Use of dihydroimidazolones for the treatment of dogs
#221Method for treating early severe diffuse acute respiratory distress syndrome
#222Abuse-proofed dosage form
#223Methods for treating multiple myeloma using 3-(4-amino-1-oxo-1,3-dihydroisoindol-2-yl)-piperidine-2,6-dione in combination with proteasome inhibitor
#224Methods for treating amyloidosis using 4-(amino)-2-(2,6-Dioxo(3-piperidyl))- isoindoline-1,3-dione
#225COMPOSITIONS FOR REDUCING RISK OF ADVERSE EVENTS CAUSED BY DRUG-DRUG INTERACTIONS
#226PHARMACEUTICAL COMPOSITIONS WITH TETRABENAZINE
#227Pharmaceutical compositions
#228Selective calcium channel antagonists
#229NS1 PROTEIN INHIBITORS
#230METHODS FOR TREATMENT OF MULTIPLE MYELOMA USING CYCLOPROPANE CARBOXYLIC ACID {2-(Is)-(3-eTHOXY-4METHOXY-PHENYL)-2-METHANESULFONYL-ETHYL}-3-OXO-2.3-DIHYDRO-1H-ISOINDOL-4-YL}-AMIDE
#231Method for treating liver diseases of various origins
#232Substituted 4-hydroxypyrimidine-5-carboxamides
#233Methods using immunomodulatory compounds for treatment of certain leukemias
#234Abuse-proofed dosage form
#235METHODS OF TREATING MULTIPLE MYELOMA USING MELPHALAN, PREDNISONE AND LENALIDOMIDE
#236Use of the phytocannabinoid cannabidivarin (CBDV) in the treatment of epilepsy
#237PROKINETICIN 1 RECEPTOR ANTAGONISTS FOR THE TREATMENT OF PAIN
#238STAT3 INHIBITORS
#239Methods of reducing symptoms in subjects using single dosage forms with tapering release rates
#240Medicament and method of diagnosis for treating subclinical Cushing's syndrome
#2415HT7 RECEPTOR LIGANDS AND COMPOSITIONS COMPRISING THE SAME
#242Method to induce fatty liver in animal
#243METHODS FOR TREATING APOLIPOPROTEIN E4-ASSOCIATED DISORDERS
#244Uses of chemicals to modulate GSK-3 signaling for treatment of bipolar disorder and other brain disorders
#245COMPOSITIONS AND METHODS FOR TREATING CONDITIONS ASSOCIATED WITH NEURONAL DYSFUNCTION
#246Method and compounds for inhibition of cell death
#247Method of treating movement disorders using barbituric acid derivatives
#248Pharmaceutical compositions of pyrimidine-2,4,6-triones
#249Methods for treatment of hepatocellular carcinoma using 3-(4-amino-1-OXO-1,3-dihydroisoindol-2-yl)-piperidine-2,6-dione
#250PDZ DOMAIN MODULATORS
#251PROCESS FOR FORMING DISULFIDE BRIDGES
#252Non-sedating barbiturate compounds as neuroprotective agents
#253Methods for treatment of follicular lymphoma using 3-(4-amino-1-oxo-1,3-dihydroisoindol-2-yl)-piperidine-2,6-dione
#254Regulation of protein synthesis
#255Composition and method for improved bioavailability and enhanced brain delivery of 5,5-diphenyl barbituric acid
#256Prolyl hydroxylase inhibitors
#257Methods and Compositions Using Immunomodulatory Compounds for The Treatment and Management of Cancers and Other Diseases
#258Methods for treatment of multiple myeloma using 3-(4-amino-1-oxo-1,3-dihydroisoindol-2-yl)-piperidine-2,6-dione in combination with a proteasome inhibitor
#259Indole compounds and their use as radiation sensitizing agents and chemotherapeutic agents
#260MEDICINAL COMPOSITIONS QUICKLY DISINTEGRATING IN THE ORAL CAVITY AND PROCESS FOR PRODUCING THE SAME
#261METHODS FOR TREATMENT OF COLORECTAL CANCER USING 3-(4-AMINO-1-OXO-1,3-DIHYDRO-ISOINDOL-2-YL)-PIPERIDINE-2,6-DIONE
#262Methods and Compositions for Targeting c-Rel
#263Stat3 inhibitors
#264COMPOSITIONS AND METHODS FOR TREATMENT OF DISEASE CAUSED BY YERSINIA SPP INFECTION
#265Opioid Combination Wafer
#266METHOD OF TREATMENT WITH PREDICTABLY BREAKABLE PHARMACEUTICAL TABLETS
#267Therapeutic or prophylactic agent for leukemia
#268Pharmaceutical compositions
#269Inhibitors of the influenza virus non-structural 1 protein
#270Method for treating multiple myeloma using 3-(4-amino-1-oxo-1,3-dihydroisoindol-2-yl)-piperidine-2,6-dione in combination with antibodies
#271METHODS FOR THE TREATMENT OF BLADDER CANCER USING 3-(4-AMINO-1-OXO-1,3-DIHYDROISOINDOL-2-YL)-PIPERIDINE-2,6-DIONE
#272COMPOSITIONS AND METHODS FOR TREATMENT OF PAIN
#273Methods for treatment prostate cancer using 3-(4-amino-1-oxo-1,3-dihydro-isoindol-2-yl)-piperidine-2,6-dione
#274PROCESS FOR THE PRODUCTION OF AN ABUSE-PROOFED DOSAGE FORM
#275Methods for treating head or neck cancer using 4-(amino)-2-(2,6-dioxo(3-piperidyl))-isoindoline-1,3-dione
#276Methods for treating multiple myeloma using 4-(amino)-2-(2,6-dioxo(3-piperidyl))-isoindoline-1,3-dione
#277Methods for treating multiple myeloma using 3-(4-amino-1-oxo-1,3-dihydroindol-2-yl)-piperidine-2,6-dione follow by autologous stem cell transplantation
#278Methods for treating sarcoma using 3-(4-amino-1-oxo-1,3-dihydroisoindol-2-yl)-piperidine-2,6-dione or 4-(amino)-2-(2,6 dioxo(3-piperidyl))-isoindoline-1,3-dione
#279FORM OF ADMINISTRATION SECURED AGAINST MISUSE
#280Methods for treating brain cancer using 3-(4-amino-1-oxo-1,3-dihydroisoindol-2-yl)-piperidine-2,6-dione or 4-(amino)-2-(2,6 dioxo(3-piperidyl))-isoindoline-1,3-dione
#281Methods for treatment of behcet's disease using 3-(4-amino-1-oxo-1,3-dihydro-isoindol-2-yl)-piperidine-2,6-dione
#282Method for treatment and management of thyroid cancer using immunomodulatory compounds
#283PREVENTING PATHOLOGICAL NERVE CELL SUICIDE (NEUROAPOPTOSIS) IN IMMATURE NERVOUS SYSTEMS
#284Methods using 3-(4-amino-1-oxo-1,3-dihydro-isoindol-2-yl)-piperidine-2,6-dione for treatment of certain leukemias
#285Method of improving bioavailability for non-sedating barbiturates
#286BARBITURIC ACID ANALOGS AS THERAPEUTIC AGENTS
#287PHARMACEUTICAL COMPOSITIONS HAVING NOVEL SCORING PATTERNS AND METHODS OF USING THOSE COMPOSITIONS
#288SEROTONERGIC AGENTS FOR TREATING SEXUAL DYSFUNCTION
#289Use of dihydroimidazolones for the treatment of dogs
#290Methods for treatment of ovarian, colorectal or pancreatic cancer using 4-(aminno)-2(2,6-dioxo(3-piperidyl)-isoindoline-1,3-dione
#291Combinations of proton pump inhibitors, sleep aids, buffers and pain relievers
#292ANTI-VIRAL USES FOR ANALOGS OF BARBITURIC ACID
#293CO-ADMINISTRATION OF ADENOSINE A1 RECEPTOR ANTAGONISTS AND ANTICONVULSANTS
#294Use of a trioxopyrimidine for the treatment and prevention of bronchial inflammatory diseases
#295Pharmaceutical compositions of pyrimidine-2,4,6-triones
#296DOSAGE FORM THAT IS SAFEGUARDED FROM ABUSE
#297Method of treating movement disorders using barbituric acid derivatives
#298Chlorine Ion Uptake Modulators and Uses Thereof
#299Protein kinase C epsilon as modulator of anxiety, alcohol consumption and self-administration of drugs of abuse
#300Protein kinase C epsilon as modulator of anxiety, alcohol consumption and self-administration of drugs of abuse